Trinity Capital (TRIN) has committed $20 million in growth capital to ABM Respiratory Care, giving investors a fresh data point on how the lender is deploying funds into health focused, revenue generating borrowers.
Trinity Capital’s latest commitment comes at a time when the share price has eased, with a 30 day share price return of 8.30% and a 90 day share price return showing a 5.21% decline. However, the stock still reflects an 8.70% year to date share price gain and a 1 year total shareholder return of 25.29%, indicating longer term momentum that contrasts with recent softness.
Scan how Trinity Capital’s latest health focused deal compares with other lenders putting money to work in similar opportunities through our hand picked list of solid balance sheet and fundamentals (25 results).
The bull case leans on Trinity Capital’s double digit revenue and net income growth, as well as the discount to analyst and intrinsic values. The bear case points to recent share price weakness. Which side do the valuation numbers support next?
Most Popular Narrative: 11.6% Undervalued
Trinity Capital’s most followed valuation narrative pegs fair value at $18.50 using a 9.32% discount rate, compared with the recent $16.36 close. This frames the stock as modestly discounted while the lender continues to lean into private credit and fee based income.
The current valuation implies that Trinity Capital is fairly valued, with the share price broadly reflecting its record AUM, growing managed funds contribution, disciplined balance sheet funding, and credit outcomes to date.
The main factor for success is that Trinity Capital continues to expand fee based managed funds and SBIC capacity so that third party capital and fund level income become a larger and durable share of overall earnings.
See why 33 investors see Trinity Capital as 12% undervalued.
Result: Fair Value of $18.50 (UNDERVALUED)
Still, the narrative can crack if Trinity Capital struggles to deploy its US$3.2b platform efficiently, or if higher funding costs squeeze the expected margin uplift.
Find out about the key risks to this Trinity Capital narrative.
Next Steps
The story so far sends mixed messages. Act while the data is fresh and evaluate it yourself by checking the 4 key rewards and 4 important warning signs.
Looking for more Trinity Capital style investment ideas?
Do not stop with a single stock. Put the same disciplined lens you used on Trinity Capital to work across the market and keep your watchlist evolving.
- Target quality at a discount by scanning for companies that combine robust fundamentals with attractive pricing through the 30 high quality undervalued stocks.
- Prioritise resilience by filtering for businesses with stronger balance sheets and steadier financial footing using the 30 resilient stocks with low risk scores.
- Get ahead of the crowd by hunting for underfollowed opportunities with solid metrics using the 20 high quality undiscovered gems.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com